ADC Therapeutics S.A. ( ADCT) - Key Metrics
ADCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.12 | -$0.11 | -$0.08 | -$0.08 |
| 2026Q1 | $0.13 | -$0.21 | -$0.19 | -$0.19 |
| 2025Q4 | $0.15 | -$0.04 | -$0.21 | -$0.21 |
| 2025Q3 | $0.12 | -$0.30 | -$0.22 | -$0.22 |
| 2025Q2 | $0.17 | -$0.50 | -$0.21 | -$0.21 |
ADCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.43 |
| 2026Q1 | 0% | -4.46 |
| 2025Q4 | 0% | -20.72 |
| 2025Q3 | 0% | -3.33 |
| 2025Q2 | 0% | -1.34 |
ADCT
Price: $1.22
52 week price:
Earnings Per Share: -0.58 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.0 million
Market Capitalization: 167.3 million